Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Trelle

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
Nature Medicine|January 3, 2025
Empagliflozin in nondiabetic individuals with calcium and uric acid kidney stones: a randomized phase 2 trialManuel A Anderegg, Simeon Schietzel, Matteo Bargagli, et al.
The Lancet. Oncology|August 14, 2017
Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation studyHema Sekhar, Marcel Zwahlen, Sven Trelle, et al.
Alimentary Pharmacology & Therapeutics|October 31, 2018
Adults with eosinophilic oesophagitis identify symptoms and quality of life as the most important outcomesEkaterina Safroneeva, Lukas Balsiger, David Hafner, et al.
BMJ (Clinical Research Ed.)|August 15, 2009
Disagreements in meta-analyses using outcomes measured on continuous or rating scales: observer agreement studyBritta Tendal, Julian P T Higgins, Peter Jüni, et al.
Journal of Clinical Epidemiology|May 16, 2017
Series: Pragmatic trials and real world evidence: Paper 6. Outcome measures in the real worldPaco M Welsing, Katrien Oude Rengerink, Sue Collier, et al.
Trials|May 14, 2025
Clinical trial budgeting approaches in Switzerland-a meta-research studyAlexandra Griessbach, Malena Chiaborelli, Klaus Ehrlich, et al.
Frontiers in Oncology|March 12, 2026
Ablatio-bilica: safety of biliary intraductal radiofrequency ablation in patients with unresectable extrahepatic biliary tract cancer undergoing systemic anti-tumor therapy: a phase II, multi-center, randomized, and controlled studyTabea Pfister, Samantha Chun Wai Chan, Sven Trelle, et al.
Journal of the National Cancer Institute|May 18, 2006
Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patientsJulia Bohlius, Jayne Wilson, Jerome Seidenfeld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2005
Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trialThomas Elter, Peter Borchmann, Holger Schulz, et al.
BMJ (Clinical Research Ed.)|May 24, 2023
Optimising prescribing in older adults with multimorbidity and polypharmacy in primary care (OPTICA): cluster randomised clinical trialKatharina Tabea Jungo, Anna-Katharina Ansorg, Carmen Floriani, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Nature Medicine|January 3, 2025
Empagliflozin in nondiabetic individuals with calcium and uric acid kidney stones: a randomized phase 2 trialManuel A Anderegg, Simeon Schietzel, Matteo Bargagli, et al.
The Lancet. Oncology|August 14, 2017
Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation studyHema Sekhar, Marcel Zwahlen, Sven Trelle, et al.
Alimentary Pharmacology & Therapeutics|October 31, 2018
Adults with eosinophilic oesophagitis identify symptoms and quality of life as the most important outcomesEkaterina Safroneeva, Lukas Balsiger, David Hafner, et al.
BMJ (Clinical Research Ed.)|August 15, 2009
Disagreements in meta-analyses using outcomes measured on continuous or rating scales: observer agreement studyBritta Tendal, Julian P T Higgins, Peter Jüni, et al.
Journal of Clinical Epidemiology|May 16, 2017
Series: Pragmatic trials and real world evidence: Paper 6. Outcome measures in the real worldPaco M Welsing, Katrien Oude Rengerink, Sue Collier, et al.
Trials|May 14, 2025
Clinical trial budgeting approaches in Switzerland-a meta-research studyAlexandra Griessbach, Malena Chiaborelli, Klaus Ehrlich, et al.
Frontiers in Oncology|March 12, 2026
Ablatio-bilica: safety of biliary intraductal radiofrequency ablation in patients with unresectable extrahepatic biliary tract cancer undergoing systemic anti-tumor therapy: a phase II, multi-center, randomized, and controlled studyTabea Pfister, Samantha Chun Wai Chan, Sven Trelle, et al.
Journal of the National Cancer Institute|May 18, 2006
Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patientsJulia Bohlius, Jayne Wilson, Jerome Seidenfeld, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2005
Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trialThomas Elter, Peter Borchmann, Holger Schulz, et al.
BMJ (Clinical Research Ed.)|May 24, 2023
Optimising prescribing in older adults with multimorbidity and polypharmacy in primary care (OPTICA): cluster randomised clinical trialKatharina Tabea Jungo, Anna-Katharina Ansorg, Carmen Floriani, et al.
Pageof 10